Login / Signup

Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats.

Valentina VozellaFaizy AhmedPaoula ChoobchianCollin B MerrillCristina ZibardiGiorgio TarziaMarco MorAndrea DurantiAndrea TontiniSilvia RivaraDaniele Piomelli
Published in: The Journal of pharmacy and pharmacology (2019)
Pain remains a major unmet medical need. The favourable pharmacokinetic and pharmacodynamic properties of URB937, along with its tolerability, encourage further development studies on this compound.
Keyphrases
  • fatty acid
  • case control
  • chronic pain
  • healthcare
  • pain management
  • open label
  • clinical trial
  • double blind
  • spinal cord
  • study protocol